AstraZeneca Pharma India Ltd. has received approval from CDSCO to import and sell Lynparza (Olaparib) in India. Lynparza will ...

The work envisages doubling of Parbhani Parli railway section in Maharashtra over 58.06 km excluding the Gangakhed yard.

The company's revenue for the quarter in the said report came at ₹15,635 crore, which is 2% lower than last year.

A claim of demand relates to IGST under Section 20 of the IGST Act, 2017 and corresponding provisions of the CGST and State ...

SPARSH is an initiative by the Indian government to streamline pension services for over 30 lakh retired defence personnel ...

Waaree Energies Ltd. has bagged a significant order for 600 MWp solar modules from one of India’s leading renewable power ...

Exide Industries has taken a significant step toward the future of energy by investing ₹99.99 crore in its wholly-owned ...

At 12:19 p.m., Ethereum, the second-largest cryptocurrency, increased 1.5% to $3,431, while Bitcoin was 3.5% lower at $94,785 ...

The IPO was oversubscribed 12.52 times on the second day of public subscription. Today is the third and last day of bidding ...

The Mumbai-based entity's overall income increased to ₹10,090 Crore from ₹9,839 Crore the previous year, according to New ...

The rHA 20% product, derived from yeast, is a highly purified alternative to human serum albumin, matching it structurally ...

According to Bernstein Research, Total's financial exposure to Adani companies is between $4 billion and $5 billion ...